For women undergoing HPV-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained slides reduces the number of colposcopies compared with current standards.
Findings based on comparison to hormonal intrauterine devices.
Screening rates are insufficient to reduce cervical cancer incidence.
Researchers sought to identify the potential influence of stress-related psychiatric disorders and stressful life events on cancer-specific mortality in women with cervical cancer.
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer.
Most lifetime QALYs seen with cytologic testing every 3 years, repeated for ASC-US.
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014.
In the absence of further intervention, in the next 50 years, an estimated 44.4 million women will be diagnosed with cervical cancer globally.
Women who used a self-screening assay for high-risk human papillomavirus had similar test results to those who were screened by a clinician.
